ANGO: SEC Form 3 filed by AngioDynamics Inc.
AngioDynamics Inc. (ANGO) filed an SEC Form 3. Historical data shows mixed stock performance post-headlines, with median moves of 1.9%. Recent events include conference participation, study results, and financial reports.
How this was made
The 30-second read
Why it matters
The filing adds a new data point to AngioDynamics' ownership structure but does not convey operational or financial changes.
Market read
A routine insider filing with limited immediate trading relevance.
What to watch
The size and identity of the reporting insider are not disclosed in the summary, limiting assessment.
Background
Form 3 is the initial statement of beneficial ownership required by the SEC when an insider first acquires shares.
Ticker impact
SEC Form 3 filing by AngioDynamics Inc. discloses a new beneficial ownership statement.
likely neutral to slight pressure as investors assess the ownership change
Form 3 filings are routine disclosures; unless the insider stake is large, price impact is typically muted.
Market effects
none
none
none
Counterpoint
The filing could signal insider confidence if the stake is sizable, warranting a modest buy consideration.
Key entities
- companyAngioDynamics Inc.
Medical device maker listed on NASDAQ under ticker ANGO.
